Rubric Capital Management LP 13D and 13G filings for Trevi Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 4:01 pm Sale |
2024-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
Rubric Capital Management LP | 4,205,129 4.710% |
-821,802 (-16.35%) |
Filing |
| 2024-11-13 4:30 pm Sale |
2024-09-30 | 13G | Trevi Therapeutics, Inc. TRVI |
Rubric Capital Management LP | 5,026,931 6.920% |
-657,489 (-11.57%) |
Filing |
| 2024-02-12 06:06 am Unchanged |
2023-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
Rubric Capital Management LP | 5,684,420 8.900% |
0 (Unchanged) |
Filing |
| 2023-02-10 4:00 pm Purchase |
2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
Rubric Capital Management LP | 5,684,420 9.490% |
5,684,420 (New Position) |
Filing |